Heidi Fields
CIK: 0001014330
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About FIELDS HEIDI
FIELDS HEIDI (SEC CIK 0001014330) files insider reports with the SEC as Director of Phathom Pharmaceuticals, Inc. (PHAT) and Director of AGILENT TECHNOLOGIES, INC. (A).
Signal8 holds 3 ownership filings by FIELDS HEIDI, all Form 4s, filed between Mar 18, 2025 and May 21, 2026. Those filings report 3 transactions, from Mar 14, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FIELDS HEIDI's filings is in FLORHAM PARK, NJ.
Recent filings by FIELDS HEIDI
Other insiders filing for Phathom Pharmaceuticals, Inc. (PHAT)
- Narula Sanjeev, Chief Financial & Bus. Officer
- Breedlove Robert Charles, Principal Accounting Officer
- Parikh Asit, Director
- Topper James N, Director
- Stenhouse Mark, Director
- COLA MICHAEL F, Director